Limited Alleviation of Lysosomal Acid Lipase Deficiency by Deletion of Matrix Metalloproteinase 12
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms252011001 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Martin Buerger und 7 weiteren Autor:innen. Beteiligte Einrichtung: Molecular Biology and Biochemistry, Gottfried Schatz Research Center, Medical University of Graz, 8010 Graz, Austria. Hauptthemen laut MEDLINE: Matrix Metalloproteinase 12, Mice, Knockout, Sterol Esterase, Wolman Disease. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: FWF Austrian Science Fund, Medical University of Graz, Austrian Science Fund (FWF).
Abstract (Originalsprache)
Lysosomal acid lipase (LAL) is the only known enzyme that degrades cholesteryl esters and triglycerides at an acidic pH. In LAL deficiency (LAL-D), dysregulated expression of matrix metalloproteinase 12 (MMP-12) has been described. The overexpression of MMP-12 in myeloid lineage cells causes an immune cell dysfunction resembling that of Lal knockout (Lal KO) mice. Both models develop progressive lymphocyte dysfunction and expansion of myeloid-derived suppressor (CD11b+ Gr-1+) cells. To study whether MMP-12 might be a detrimental contributor to the pathology of LAL-D, we have generated Lal/Mmp12 double knockout (DKO) mice. The phenotype of Lal/Mmp12 DKO mice closely resembled that of Lal KO mice, while the weight and morphology of the thymus were improved in Lal/Mmp12 DKO mice. Cytological examination of blood smears showed a mildly reversed lymphoid-to-myeloid shift in DKO mice. Despite significant decreases in CD11b+ Ly6G+ cells in the peripheral blood, bone marrow, and spleen of Lal/Mmp12 DKO mice, the hematopoietic bone marrow progenitor compartment and markers for neutrophil chemotaxis were unchanged. Since the overall severity of LAL-D remains unaffected by the deletion of Mmp12, we conclude that MMP-12 does not represent a viable target for treating the inflammatory pathology in LAL-D.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Molecular Biology and Biochemistry, Gottfried Schatz Research Center, Medical University of Graz, 8010 Graz, Austria.
- Department of Medicine and Surgery, University of Parma, 43126 Parma, Italy.
- Division of Pharmacology, Otto Loewi Research Center for Vascular Biology, Immunology, and Inflammation, Medical University of Graz, 8010 Graz, Austria.
- Division of Hematology, Medical University of Graz, 8010 Graz, Austria.
- Center for Pathobiochemistry & Genetics, Medical University of Vienna, 1090 Vienna, Austria.
- BioTechMed-Graz, 8010 Graz, Austria.
ORCID-Profile: Melina Amor, Valentina Bianco, Armin Zebisch, Thomas Weichhart, Dagmar Kratky
Förderung
- FWF Austrian Science Fund
- Medical University of Graz
- Austrian Science Fund (FWF)
- Ph.D. program “Molecular Medicine” of the Medical University of Graz
Zitieren
APA
Buerger, M., Amor, M., Akhmetshina, A., Bianco, V., Perfler, B., Zebisch, A., Weichhart, T., & Kratky, D. (2024). Limited Alleviation of Lysosomal Acid Lipase Deficiency by Deletion of Matrix Metalloproteinase 12. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms252011001
Vancouver
Buerger M, Amor M, Akhmetshina A, Bianco V, Perfler B, Zebisch A, et al. Limited Alleviation of Lysosomal Acid Lipase Deficiency by Deletion of Matrix Metalloproteinase 12. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms252011001
BibTeX
@article{Buerger2024,
author = {Buerger, Martin and Amor, Melina and Akhmetshina, Alena and Bianco, Valentina and Perfler, Bianca and Zebisch, Armin and Weichhart, Thomas and Kratky, Dagmar},
title = {Limited Alleviation of Lysosomal Acid Lipase Deficiency by Deletion of Matrix Metalloproteinase 12},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms252011001}
}
EUVIMED